RHENMAN & PARTNERS ASSET MANAGEMENT AB Aerie Pharmaceuticals, Inc. Transaction History

RHENMAN & PARTNERS ASSET MANAGEMENT AB portfolio value:

$0
portfolio value

RHENMAN & PARTNERS ASSET MANAGEMENT AB quarter portfolio value change:

+101.73%
quarter

Aerie Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -100.00% -562.35K shares -4.21M $15.13 0
Q2 2022 share Decrease -4.56% -26.85K shares -1.14M $7.5 562.35K
Q1 2022 share Decrease -21.44% -160.8K shares -16K $9.1 589.2K
Q4 2021 share 0.00% 0 shares -3.17M $7.17 750K
Q3 2021 share 0.00% 0 shares -3.45M $11.4 750K
Q2 2021 share 0.00% 0 shares -1.39M $16.01 750K
Q1 2021 share Decrease -11.76% -100K shares 1.91M $17.87 750K
Q4 2020 share 0.00% 0 shares 1.47M $13.51 850K
Q3 2020 share Increase +44.07% 260K shares 1.29M $11.77 850K
Q2 2020 share Decrease -18.06% -130K shares -1.01M $14.76 590K
Q1 2020 share Increase +2.86% 20K shares -7.19M $13.5 720K
Q4 2019 share Increase +47.37% 225K shares 7.78M $24.17 700K
Q3 2019 share Increase +82.69% 215K shares 1.44M $19.22 475K
Q2 2019 share 0.00% 0 shares -4.66M $29.55 260K
Q1 2019 share Decrease -7.14% -20K shares 2.24M $47.5 260K
Q4 2018 share Increase +55.56% 100K shares -971K $36.1 280K
Q3 2018 share Increase +157.14% 110K shares 6.35M $61.55 180K
Q2 2018 share Increase +75.00% 30K shares 2.55M $67.55 70K
Q1 2018 share Decrease -68.46% -86.82K shares -5.40M $54.25 40K
Q4 2017 share Increase +4.88% 5.89K shares 1.70M $59.75 126.82K
Q3 2017 share Increase +61.24% 45.93K shares 1.93M $48.6 120.93K
Q2 2017 share Decrease -11.76% -10K shares 86K $52.55 75K
Q1 2017 share Increase +142.86% 50K shares 2.53M $45.35 85K
Q4 2016 share Increase 0.00% 35K shares 1.32M $37.85 35K